A Study of Metformin to Improve Cardiac Function After LVAD Implantation
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 108 participants.
Also called NCT07666698
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 108 participants
- Registry
-
NCT07666698
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07666698. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-01 (actual); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Metformin to Improve Cardiac Function After LVAD Implantation
- Condition
- Heart Failure
- Condition
- Left Ventricular Assist Device
- Intervention (Drug)
- Metformin Hydrochloride
- Intervention (Drug)
- Placebo
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Record details
- Record id
cardio:ct-nct07666698- Content hash
38efb7b4246bfe358c2f839156fc8ed615b905033e075ea6521395fe40d512de